Supernus Pharmaceuticals, Inc.
SUPN Real Time Price USDRecent trades of SUPN by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by SUPN's directors and management
Government lobbying spending instances
-
$20,000 Oct 17, 2024 Issue: Medicare/Medicaid Health Issues
-
$20,000 Jul 15, 2024 Issue: Medicare/Medicaid Health Issues
-
$20,000 Apr 17, 2024 Issue: Medicare/Medicaid Health Issues
-
$20,000 Oct 20, 2023 Issue: Medicare/Medicaid Health Issues
-
$20,000 Jul 20, 2023 Issue: Medicare/Medicaid Health Issues
-
$20,000 Apr 17, 2023 Issue: Medicare/Medicaid Health Issues
-
$20,000 Feb 07, 2023 Issue: Medicare/Medicaid Health Issues
-
$20,000 Oct 19, 2022 Issue: Medicare/Medicaid Health Issues
Estimated quarterly lobbying spending
New patents grants
Federal grants, loans, and purchases
- $10,151 2022-10-12 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $0 2022-09-09 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $10,151 2022-08-19 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $10,151 2022-07-22 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $10,151 2022-02-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded from public contracts
Number of mentions of SUPN in WallStreetBets Daily Discussion
Recent insights relating to SUPN
Recent picks made for SUPN stock on CNBC
ETFs with the largest estimated holdings in SUPN
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SUPN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.